Paeds

Constipation in Children

5 min

❍ At a glance

  • Overflow faecal incontinence - frequent small liquid accidents - is not diarrhoea. It is faecal loading with overflow. Stopping laxatives makes it worse. This distinction is consistently missed.
  • Disimpaction must happen before maintenance therapy works. Macrogol (Movicol Paediatric Plain) is the agent of choice: escalate doses over 6-8 days until impaction clears (soft, liquid-ish stools for 24 hours), then drop to maintenance dose.3
  • Maintenance treatment should continue for a minimum of 6 weeks after successful bowel habit is established - often 3-6 months or longer. Relapse is common if laxatives are stopped too early. Taper gradually, do not stop abruptly.
  • Red flags for organic cause: onset in the first month of life, delayed meconium passage beyond 48 hours (consider Hirschsprung's disease), ribbon stools, failure to thrive, sacral dimple, neurological signs in lower limbs.

Functional constipation is one of the most common gastrointestinal problems of childhood, accounting for approximately 3-5% of all paediatric primary care visits.1 It causes significant distress to children and families, is frequently under-treated, and has a high rate of relapse if laxative treatment is stopped too early. The majority of childhood constipation is functional (no underlying organic cause), but red flags for organic causes must be excluded.

❍ Diagnosis and red flags

Functional constipation is a clinical diagnosis using Rome IV criteria: two or more of the following for at least 4 weeks (under 4 years) or at least 2 months (older children): two or fewer defaecations per week; at least one episode per week of incontinence after toilet training; retentive posturing or excessive voluntary stool retention; painful or hard bowel motions; large faecal mass in the rectum; large diameter stools that obstruct the toilet.2

The clinical picture often involves a cycle of painful defaecation leading to stool withholding, harder and larger stools, more pain, and more withholding. Once faecal impaction accumulates in the rectum, overflow incontinence can develop - parents may describe frequent small liquid or paste-like accidents that look like diarrhoea. This is not diarrhoea. Treating it as such (stopping laxatives) makes the underlying constipation worse. The Bristol Stool Chart is a useful objective tool: type 1-2 indicates constipation; type 3-4 is normal; type 5-7 indicates loose stools.

Red flags requiring investigation: onset in the first month of life or delayed meconium passage beyond 48 hours (consider Hirschsprung's disease); ribbon stools; failure to thrive; abdominal distension; sacral dimple or skin changes at the base of the spine (suggest spinal dysraphism); neurological signs in the lower limbs; blood in the stool without a clear anorectal cause.1 Plain abdominal X-ray is not recommended as a routine tool for diagnosing constipation - clinical assessment is sufficient.

❍ Management: disimpaction and maintenance

Disimpaction first if faecal impaction is present: impaction must be cleared before maintenance laxative treatment is effective. Macrogol (polyethylene glycol with electrolytes) is the agent of choice in NZ. For children aged 1-5 years, start with 2 sachets per day (Movicol Paediatric Plain 13.8 g sachets) and increase by 2 sachets every 2 days up to a maximum of 8 sachets per day, until the impaction clears - indicated by soft, liquid-ish stools for 24 hours.3 Warn parents that high disimpaction doses may produce cramping and watery stools.

Maintenance: once disimpaction is achieved, reduce to a maintenance dose sufficient to produce soft, comfortable stools (Bristol 3-4) once daily. Macrogol is first-line (typically 1 sachet per day in children aged 1-5, adjusted to response). Lactulose is an alternative but less effective and causes more bloating. Stimulant laxatives (senna, bisacodyl) may be added as a second agent if macrogol alone is insufficient. Continue maintenance for a minimum of 6 weeks after successful bowel habit is established, often 3-6 months or longer. Taper the dose gradually rather than stopping abruptly.

Behavioural: regular toilet sits after meals (exploiting the gastrocolic reflex), a footstool to support the feet, and positive reinforcement are important. Toilet anxiety is common in children who have experienced painful defaecation - a calm, non-pressured approach with praise (not punishment) is essential. Increase fluid intake and dietary fibre; a 2-4 week cow's milk elimination trial may be worth attempting in toddlers where macrogol response is poor and there are associated GI symptoms.

❍ Referral criteria

Refer to paediatric gastroenterology or general paediatrics for: any red flag features (see above); failure to respond to adequate macrogol therapy after 3 months; severe faecal incontinence requiring specialist behavioural support; suspected Hirschsprung's disease (rectal suction biopsy in secondary care); constipation associated with significant failure to thrive.

References

  1. National Institute for Health and Care Excellence (NICE). Constipation in children and young people: diagnosis and management. NICE guideline CG99. London: NICE; 2010, updated 2017.
  2. Hyams JS, Di Lorenzo C, Saps M, et al. Childhood functional gastrointestinal disorders: child/adolescent. Gastroenterology. 2016;150(6):1456-1468. (Rome IV criteria.)
  3. New Zealand Formulary for Children (NZFc). Macrogol 3350 with electrolytes (Movicol Paediatric Plain). Auckland: New Zealand Formulary; 2024. Available from: nzfchildren.org.nz